Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Vet Parasitol ; 306: 109717, 2022 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-35606218

RESUMO

Babesia rossi causes severe morbidity and mortality in dogs in sub-Saharan Africa, and the complications associated with this disease are likely caused by an unfocused, excessive inflammatory response. During this experimental B. rossi study we investigated inflammatory marker and cytokine kinetics during infection and after treatment. We aimed to determine whether infectious dose and treatment would influence the progression of the inflammatory response and clinical disease. Six healthy male beagle dogs formed the study population, one was used to raise the infectious inoculum, three were administered a high B. rossi infectious dose (HD group) and two a low infectious dose (LD group). Clinical examination, complete blood count (CBC) and C-reactive protein (CRP) were determined daily. Cytokines were quantified on stored plasma collected during the study, using a canine specific cytokine magnetic bead panel (Milliplex©). The experiment was terminated and treatment administered when predetermined experimental or humane endpoints were reached. Parasitemia occurred on day 1 and 3 in the HD and LD groups respectively. The rate of increase in parasitemia in the HD group was significantly faster than that seen in the LD group. Significant differences were found in heart rate, blood pressure, interferon gamma (INFγ), keratinocyte chemoattractant (KC), INFγ-induced protein 10 (IP10), granulocyte-macrophage colony-stimulating factor (GM-CSF), monocyte chemoattractant protein 1 (MCP1), tumor necrosis factor alpha (TNFα), interleukin 2 (IL-2), IL-6, IL-7, IL-8, IL-10 IL-15, IL-18, CRP, neutrophils and monocytes between groups at multiple time points during the course of the infection. Our findings suggest that the initiation of inflammation occurs before the onset of clinical disease in B. rossi infection and infectious dose influences the onset of the inflammatory response. Treatment enhances the inflammatory response in the immediate post-treatment period which may contribute to disease associated complications. Finally, we found that there is an imbalance in pro/anti-inflammatory cytokine concentrations during infection which may promote parasite replication.


Assuntos
Babesia , Babesiose , Doenças do Cão , Animais , Babesiose/parasitologia , Citocinas , Doenças do Cão/parasitologia , Cães , Cinética , Masculino , Parasitemia/veterinária
2.
N Z Vet J ; 61(4): 217-22, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-23477413

RESUMO

Canine parvovirus (CPV) enteritis has, since its emergence in 1978, remained a common and important cause of morbidity and mortality in young dogs. The continued incidence of parvoviral enteritis is partly due to the virus' capability to evolve into more virulent and resistant variants with significant local gastrointestinal and systemic inflammatory sequelae. This paper reviews current knowledge on historical-, signalment-, and clinical factors as well as several haematological-, biochemical- and endocrine parameters that can be used as diagnostic and prognostic biomarkers in CPV enteritis. These factors include season of presentation, purebred nature, bodyweight, vomiting, leukopaenia, lymphopaenia, thrombocytopaenia, hypercoagulability, hypercortisolaemia, hypothyroxinaemia, hypoalbuminaemia, elevated C-reactive protein and tumour necrosis factor, hypocholesterolaemia and hypocitrullinaemia. Factors contributing to the manifestations of CPV infection are multiple with elements of host, pathogen, secondary infections, underlying stressors and environment affecting severity and outcome. The availability of several prognosticators has made identification of patients at high risk of death and their subsequent targeted management more rewarding.


Assuntos
Enterite/veterinária , Infecções por Parvoviridae/veterinária , Parvovirus Canino , Animais , Biomarcadores , Cães , Enterite/patologia , Enterite/virologia , Infecções por Parvoviridae/patologia , Infecções por Parvoviridae/virologia
3.
Parasite Immunol ; 30(1): 1-12, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18086011

RESUMO

Bacillus Calmette-Guérin (BCG) infection of the spleen is a potent modifier of splenic function. Prior to malaria infection, we infected two mouse strains of differing susceptibility to Plasmodium chabaudi AS (C57BL/6 and A/J) with this mycobacterium. We then evaluated aspects of spleen cell composition, architecture and cytokine expression, and correlated these with the outcome. BCG preinfection resulted in protection of the A/J mice but paradoxically resulted in mortality of the C57BL/6 mice. The latter developed higher parasitaemias that peaked earlier than the A/J mice rendered resistant by BCG. BCG infection induced remarkable changes to splenic histology examined by H&E staining, but there were no consistent differences between mouse strains. C57BL/6 mice had higher absolute numbers of all immune cell phenotypes than did A/J mice, and higher macrophage and dendritic cell proportions. BCG-induced resistance in A/J mice was associated with an increased CD4+ expression of IFN-gamma whilst induced death in C57BL/6 mice was associated with excessive IFN-gamma expression. A moderate TH1 response in the A/J model may have been responsible for the improved survival, and an excessive TH1 response in the C57BL/6 model may have contributed to their death.


Assuntos
Vacina BCG/imunologia , Malária/imunologia , Mycobacterium bovis/imunologia , Plasmodium chabaudi , Baço/imunologia , Animais , Subpopulações de Linfócitos B/imunologia , Linfócitos T CD4-Positivos/imunologia , Feminino , Interferon gama/imunologia , Interferon gama/metabolismo , Macrófagos/imunologia , Malária/parasitologia , Camundongos , Camundongos Endogâmicos A , Camundongos Endogâmicos C57BL , Parasitemia/imunologia , Plasmodium chabaudi/imunologia , Baço/citologia , Baço/patologia , Esplenomegalia , Subpopulações de Linfócitos T/imunologia
4.
J S Afr Vet Assoc ; 77(4): 175-8, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17458340

RESUMO

Pigmented serum, usually due to free haemoglobin and/or bilirubin, is a common finding in dogs with babesiosis, resulting in interference with all biochemical tests that rely on photochemistry. This is particularly true of urea and creatinine determinations, complicating the diagnosis of acute renal failure, which is a serious complication of babesiosis. A disproportionately raised serum urea concentration of unknown origin occurs in severely anaemic canine babesiosis patients and gives rise to an increased serum urea:creatinine ratio. The assay for cystatin-C, an excellent measure of glomerular filtration rate, is unaffected by free serum haemoglobin, and due to its different intrinsic origins, is free of influence by the metabolic derangements and organ pathology, other than renal disease, encountered in canine babesiosis. Serum cystatin-C was used to compare the concentrations of serum urea and serum creatinine in dogs with the severely anaemic form of canine babesiosis as well as a canine babesiosis-free reference group. Mean serum urea and mean serum urea:creatinine ratio were significantly elevated in the babesia-infected group relative to the reference population in this study. Mean serum creatinine and mean serum cystatin-C were within the reference ranges. Therefore an elevated urea:creatinine ratio in canine babesiosis in the presence of a normal serum creatinine concentration is considered to be caused by an elevated serum urea concentration and is most likely of non-renal origin. Serum creatinine was therefore as specific a measure of renal function as serum cystatin-C in canine babesiosis in this study. The sensitivity of serum creatinine as a measure of renal function was not established by this study. Serum urea, however, proved to be of little use compared to serum cystatin-C and serum creatinine. Serum urea should therefore not be used to diagnose renal failure in canine babesiosis.


Assuntos
Babesiose/veterinária , Creatinina/sangue , Doenças do Cão/sangue , Ureia/sangue , Animais , Babesiose/sangue , Babesiose/complicações , Babesiose/diagnóstico , Estudos de Casos e Controles , Cistatina C , Cistatinas/sangue , Diagnóstico Diferencial , Doenças do Cão/diagnóstico , Cães , Nefropatias/diagnóstico , Nefropatias/etiologia , Nefropatias/veterinária , Estudos Prospectivos , Valores de Referência
5.
Eur J Biochem ; 266(3): 855-64, 1999 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-10583379

RESUMO

Previous studies have shown that palmitoyl-carnitine is an anti-proliferative agent and a protein kinase C inhibitor. Two new palmitoyl-carnitine analogs were synthesized by replacing the ester bond with a metabolically more stable ether bond. An LD50 value in the nM range was found in anti-proliferative assays using HL-60 cells and was dependent on the alkyl-chain length. The inhibitory action of these water-soluble compounds on protein kinase C in vitro was greatly increased with respect to palmitoyl-carnitine and was dependent on the length of the alkyl chain. Its effect was mediated by an increase in the enzyme's requirement for phosphatidylserine. Inhibition of the in situ phosphorylation of a physiological platelet protein kinase C substrate and of phorbol ester-induced differentiation of HL-60 cells was also observed. Finally, to test for isoenzyme selectivity, several human recombinant protein kinase C isoforms were used. Only the Ca2+-dependent classic protein kinase Cs (alpha, betaIota, betaIotaIota and gamma) were inhibited by these compounds, yet the activities of casein kinase I, Ca2+/calmodulin-dependent kinase and cAMP-dependent protein kinase were unaffected. Thus, these novel inhibitors appear to be both protein kinase C and isozyme selective. They may be useful in assessing the individual roles of protein kinase C isoforms in cell proliferation and tumor development and may be rational candidates for anti-neoplasic drug design.


Assuntos
Carnitina/análogos & derivados , Inibidores Enzimáticos/farmacologia , Isoenzimas/antagonistas & inibidores , Proteína Quinase C/antagonistas & inibidores , Animais , Antineoplásicos/química , Antineoplásicos/farmacologia , Encéfalo/enzimologia , Carnitina/farmacologia , Diferenciação Celular/efeitos dos fármacos , Desenho de Fármacos , Células HL-60 , Humanos , Técnicas In Vitro , Indóis/farmacologia , Ratos , Acetato de Tetradecanoilforbol/farmacologia
6.
J S Afr Vet Assoc ; 63(2): 70-3, 1992 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-1501211

RESUMO

A case of diffuse malignant peritoneal mesothelioma in a 7-week-old puppy is reported. The puppy presented with a recurrent abdominal effusion. An exploratory laparotomy revealed extensive adhesions. Necropsy findings included pleural thickening, and enlargement of the renal and anterior mediastinal lymph nodes. The microscopic features were typical of primary desmoplastic diffuse mesothelioma of the peritoneum and pleura with secondary lymph node metastasis (renal and anterior mediastinal). The tumour was classified as epithelial in type. The extent of the tumour and the distant metastasis were considered to reflect a high degree of malignancy. A congenital origin was suspected.


Assuntos
Doenças do Cão/patologia , Mesotelioma/veterinária , Neoplasias Peritoneais/veterinária , Animais , Cães , Feminino , Mesotelioma/patologia , Neoplasias Peritoneais/patologia , Peritônio/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA